e-learning
resources
Vienna 2009
Monday, 14.09.2009
Lung infections; diagnostic and therapeutic problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary vein stenosis (PVS) after radiofrequency ablation (RFA) for atrial fibrillation
P. K. Yablonsky, V. K. Sukhov, E. A. Shloydo, V. N. Golovin, T. A. Fyodorova, I. N. Kochanov, E. V. Pavlushkov (Saint-Petersburg, Russian Federation)
Source:
Annual Congress 2009 - Lung infections; diagnostic and therapeutic problems
Session:
Lung infections; diagnostic and therapeutic problems
Session type:
Thematic Poster Session
Number:
2210
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. K. Yablonsky, V. K. Sukhov, E. A. Shloydo, V. N. Golovin, T. A. Fyodorova, I. N. Kochanov, E. V. Pavlushkov (Saint-Petersburg, Russian Federation). Pulmonary vein stenosis (PVS) after radiofrequency ablation (RFA) for atrial fibrillation. Eur Respir J 2009; 34: Suppl. 53, 2210
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Pulmonary veno-occlusive disease as a consequence of catheter ablation of atrial fibrillation
Source: Eur Respir J 2001; 18: Suppl. 33, 522s
Year: 2001
Pulmonary vein stenosis after pulmonary vein isolation for atrial fibrillation: diagnosis and treatment
Source: International Congress 2017 – Open questions in pulmonary vascular diseases
Year: 2017
Surgical treatment of pulmonary hypertension: thromboendarterectomy, atrial septostomy & transplantation
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
Incidence of atrial fibrillation after lung resection surgery and corelation with right atrial strain
Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease
Year: 2020
Successful multimodality managements of severe pulmonary artery hypertension in pregnancy with VA-ECMO and atrial septostomy using stent
Source: International Congress 2019 – CCC Respiratory critical care
Year: 2019
Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 1343-1348
Year: 2011
Right ventricular reverse remodelling after balloon pulmonary angioplasty
Source: Eur Respir J 2014; 43: 1394-1402
Year: 2014
Double-lung transplantation followed by delayed percutaneous repair for atrial septal defect-associated pulmonary arterial hypertension
Source: Eur Respir J, 59 (1) 2102388; 10.1183/13993003.02388-2021
Year: 2022
Atrial flutter and fibrillation in patients with chronic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Long-term survival in pulmonary hypertension with atrial septostomy: a single center experience
Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Year: 2020
Paroxysmal atrial fibrillation as a symptom of pulmonary embolism
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006
Balloon pulmonary angioplasty in sarcoid-related pulmonary hypertension
Source: Eur Respir J, 51 (1) 1701502; 10.1183/13993003.01502-2017
Year: 2018
Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation
Source: International Congress 2018 – PG19 Heart-lung interaction
Year: 2018
Pulmonary embolism in noncoagulated patients with chronic atrial fibrillation at admission
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006
Balloon pulmonary angioplasty (BPA) for inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
Right ventricular reverse remodeling after balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology
Year: 2014
Right atrial enlargement and prognosis in the hemodinamically stable pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012
Percutaneous transluminal pulmonary angioplasty improves biventricular cardiac functions in patients with chronic thromboembolic pulmonary hypertension - A cardiac magnetic resonance study-
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept